一项比较吗氯贝胺与吗氯贝胺加人际心理治疗对恶劣心境障碍治疗效果的随机对照试验。
A randomized controlled trial comparing moclobemide and moclobemide plus interpersonal psychotherapy in the treatment of dysthymic disorder.
作者信息
de Mello M F, Myczcowisk L M, Menezes P R
机构信息
Service of Psychiatry and Medical Psychology, Hospital do Servidor Publico Estadual, São Paulo, Brazil.
出版信息
J Psychother Pract Res. 2001 Spring;10(2):117-23.
Abstract
The authors compared the outcomes of 35 outpatients with dysthymic disorder randomized to receive either treatment with moclobemide and interpersonal therapy (IPT) or moclobemide and routine clinical management. Diagnosis was based on the ICD-10 symptom checklist. Patients were evaluated by trained raters using the 17-item Hamilton Rating Scale for Depression (Ham-D), Montgomery-Asberg Depression Rating Scale (MADRS), Global Assessment of Functioning, and Quality of Life and Satisfaction Questionnaire at baseline, 12, 24, and 48 weeks. Patients in both treatment groups showed statistically significant improvement in all measures across time. There was a nonsignificant trend toward lower scores on Ham-D and MADRS for patients in the moclobemide plus IPT group. Longer, better-powered trials should be carried out to study the efficacy of IPT plus antidepressant medication in the treatment of dysthymic disorder.
摘要
作者比较了35例被随机分配接受吗氯贝胺与人际关系疗法（IPT）联合治疗或吗氯贝胺与常规临床管理的恶劣心境障碍门诊患者的治疗结果。诊断基于国际疾病分类第10版（ICD - 10）症状清单。在基线、12周、24周和48周时，由经过培训的评估者使用17项汉密尔顿抑郁评定量表（Ham - D）、蒙哥马利 - 阿斯伯格抑郁评定量表（MADRS）、功能总体评定量表以及生活质量与满意度问卷对患者进行评估。两个治疗组的患者在所有测量指标上随时间均显示出具有统计学意义的改善。吗氯贝胺加IPT组患者的Ham - D和MADRS得分有降低的趋势，但无统计学意义。应开展规模更大、效能更高的试验来研究IPT加抗抑郁药物治疗恶劣心境障碍的疗效。
相似文献
1
A randomized controlled trial comparing moclobemide and moclobemide plus interpersonal psychotherapy in the treatment of dysthymic disorder.一项比较吗氯贝胺与吗氯贝胺加人际心理治疗对恶劣心境障碍治疗效果的随机对照试验。
J Psychother Pract Res. 2001 Spring;10(2):117-23.
2
A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.度洛西汀与安慰剂治疗非重症慢性抑郁症的随机对照试验。
J Clin Psychiatry. 2012 Jul;73(7):984-91. doi: 10.4088/JCP.11m07230.
3
4
Solving interpersonal problems correlates with symptom improvement in interpersonal psychotherapy: preliminary findings.解决人际问题与人际心理治疗中的症状改善相关：初步研究结果。
J Nerv Ment Dis. 2006 Jan;194(1):15-20. doi: 10.1097/01.nmd.0000195314.80210.41.
5
Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.度洛西汀50毫克/天和100毫克/天治疗重度抑郁症：一项为期8周的III期多中心随机双盲安慰剂对照平行组试验及三项研究的事后汇总分析。
Clin Ther. 2009 Jun;31 Pt 1:1405-23. doi: 10.1016/j.clinthera.2009.07.006.
6
Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs.基层医疗中针对恶劣心境障碍患者的舍曲林和/或人际心理治疗：6个月疗效及成本对比与2年纵向随访
J Affect Disord. 2002 Apr;68(2-3):317-30. doi: 10.1016/s0165-0327(01)00343-3.
7
Efficacy of Interpersonal Psychotherapy plus pharmacotherapy in chronically depressed inpatients.人际心理治疗联合药物治疗对慢性抑郁症住院患者的疗效。
J Affect Disord. 2008 Jul;109(1-2):65-73. doi: 10.1016/j.jad.2007.10.013. Epub 2007 Dec 11.
8
Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.艾司西酞普兰与西酞普兰治疗重度抑郁症的疗效及耐受性：一项针对成年门诊患者的为期6周的多中心、前瞻性、随机、双盲、活性药物对照研究。
Clin Ther. 2007 Nov;29(11):2319-32. doi: 10.1016/j.clinthera.2007.11.014.
9
Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.在治疗首发重性抑郁障碍中，低剂量阿立哌唑辅助标准剂量舍曲林治疗的随机、双盲、对照研究。
J Clin Psychopharmacol. 2011 Oct;31(5):563-8. doi: 10.1097/JCP.0b013e31822bb0db.
10
Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.艾司西酞普兰治疗对重度抑郁症和广泛性焦虑症患者生活质量享受与满意度问卷评分的影响。
Int Clin Psychopharmacol. 2008 Sep;23(5):276-86. doi: 10.1097/YIC.0b013e328303ac5f.
引用本文的文献
1
What do we know about long-term treatment outcomes for severe depressive disorders?我们对重度抑郁症的长期治疗结果了解多少？
BJPsych Open. 2020 Mar 17;6(2):e28. doi: 10.1192/bjo.2020.10.
2
A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression.心理治疗、药物治疗及其联合应用对成人抑郁症治疗效果的网状Meta分析。
World Psychiatry. 2020 Feb;19(1):92-107. doi: 10.1002/wps.20701.
3
Long-term outcomes of trials in the National Institute for Health and Care Excellence depression guideline.英国国家卫生与临床优化研究所抑郁症指南中试验的长期结果。
BJPsych Open. 2019 Sep 9;5(5):e81. doi: 10.1192/bjo.2019.65.
4
Is Interpersonal Psychotherapy Infinitely Adaptable? A Compendium of the Multiple Modifications of IPT.人际心理治疗是否具有无限适应性？人际心理治疗多种修改版本概览。
Am J Psychother. 2014;68(4):385-416. doi: 10.1176/appi.psychotherapy.2014.68.4.385.
5
Improving work outcomes of dysthymia (persistent depressive disorder) in an employed population.改善就业人群中恶劣心境（持续性抑郁障碍）的工作成果。
Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):352-9. doi: 10.1016/j.genhosppsych.2015.04.001. Epub 2015 Apr 8.
6
Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis.在抑郁和焦虑障碍中，将心理治疗与抗抑郁药物联合使用：一项荟萃分析。
World Psychiatry. 2014 Feb;13(1):56-67. doi: 10.1002/wps.20089.
7
Effect of psychosocial interventions on social functioning in depression and schizophrenia: meta-analysis.心理社会干预对抑郁症和精神分裂症患者社会功能的影响：荟萃分析。
Br J Psychiatry. 2013 Apr;202(4):253-60. doi: 10.1192/bjp.bp.112.118018.
8
The effectiveness of individual interpersonal psychotherapy as a treatment for major depressive disorder in adult outpatients: a systematic review.个体人际心理治疗治疗成人门诊患者重性抑郁障碍的疗效：系统评价。
BMC Psychiatry. 2013 Jan 11;13:22. doi: 10.1186/1471-244X-13-22.
9
Combination of pharmacotherapy and psychotherapy in the treatment of chronic depression: a systematic review and meta-analysis.药物治疗联合心理治疗慢性抑郁症的疗效：系统评价与 Meta 分析。
BMC Psychiatry. 2012 Jun 13;12:61. doi: 10.1186/1471-244X-12-61.
10
Interpersonal psychotherapy: past, present and future.人际心理治疗：过去、现在和未来。
Clin Psychol Psychother. 2012 Mar-Apr;19(2):99-105. doi: 10.1002/cpp.1774. Epub 2012 Feb 14.
本文引用的文献
1
A rating scale for depression.一种抑郁症评定量表。
J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56.
2
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.奈法唑酮、认知行为分析心理治疗系统及其联合应用治疗慢性抑郁症的比较。
N Engl J Med. 2000 May 18;342(20):1462-70. doi: 10.1056/NEJM200005183422001.
3
Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.吗氯贝胺与丙咪嗪治疗慢性抑郁症（心境恶劣）：一项国际双盲、安慰剂对照试验。国际协作研究组
Int Clin Psychopharmacol. 1997 Jul;12(4):183-93. doi: 10.1097/00004850-199707000-00001.
4
Psychiatric assessment instruments developed by the World Health Organization.世界卫生组织开发的精神科评估工具。
Soc Psychiatry Psychiatr Epidemiol. 1996 Mar;31(2):55-69. doi: 10.1007/BF00801901.
5
Recovery after 5 years of unremitting major depressive disorder.重度抑郁症持续5年后的康复情况。
Arch Gen Psychiatry. 1996 Sep;53(9):794-9. doi: 10.1001/archpsyc.1996.01830090040006.
6
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.一项比较舍曲林和丙咪嗪治疗心境恶劣障碍的安慰剂对照随机临床试验。
Arch Gen Psychiatry. 1996 Sep;53(9):777-84. doi: 10.1001/archpsyc.1996.01830090023004.
7
Psychotherapy for dysthymic disorder.恶劣心境障碍的心理治疗。
Psychiatr Clin North Am. 1996 Mar;19(1):133-49. doi: 10.1016/s0193-953x(05)70278-1.
8
Pharmacotherapy for chronic depression.慢性抑郁症的药物治疗。
Psychiatr Clin North Am. 1996 Mar;19(1):121-32. doi: 10.1016/s0193-953x(05)70277-x.
9
Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.生活质量享受与满意度问卷：一种新的测量方法。
Psychopharmacol Bull. 1993;29(2):321-6.
10
Cognitive-behavior therapy for chronically depressed patients. A controlled pilot study.针对慢性抑郁症患者的认知行为疗法。一项对照性初步研究。
J Nerv Ment Dis. 1982 May;170(5):295-301. doi: 10.1097/00005053-198205000-00007.
Zotero 插件